Rofida Albash

850 total citations
26 papers, 685 citations indexed

About

Rofida Albash is a scholar working on Pharmaceutical Science, Dermatology and Molecular Biology. According to data from OpenAlex, Rofida Albash has authored 26 papers receiving a total of 685 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmaceutical Science, 6 papers in Dermatology and 5 papers in Molecular Biology. Recurrent topics in Rofida Albash's work include Advancements in Transdermal Drug Delivery (13 papers), Advanced Drug Delivery Systems (8 papers) and Dermatology and Skin Diseases (5 papers). Rofida Albash is often cited by papers focused on Advancements in Transdermal Drug Delivery (13 papers), Advanced Drug Delivery Systems (8 papers) and Dermatology and Skin Diseases (5 papers). Rofida Albash collaborates with scholars based in Egypt, Saudi Arabia and Mexico. Rofida Albash's co-authors include Mohamed A. El-Nabarawi, Hanan Refai, Aly A. Abdelbary, Mariam Hassan, Abdulaziz Mohsen Al-mahallawi, Menna M. Abdellatif, Shaimaa Mosallam, Noha M. Badawi, Carol Yousry and Maha M. Abdel‐Fattah and has published in prestigious journals such as Scientific Reports, Molecules and International Journal of Pharmaceutics.

In The Last Decade

Rofida Albash

26 papers receiving 674 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rofida Albash Egypt 15 420 143 115 77 69 26 685
Menna M. Abdellatif Egypt 13 411 1.0× 128 0.9× 83 0.7× 76 1.0× 80 1.2× 30 664
Zaida Urbán‐Morlán Mexico 10 191 0.5× 85 0.6× 95 0.8× 65 0.8× 93 1.3× 12 480
Sureewan Duangjit Thailand 13 513 1.2× 212 1.5× 141 1.2× 106 1.4× 46 0.7× 45 747
Lalit Kumar India 14 274 0.7× 139 1.0× 96 0.8× 54 0.7× 121 1.8× 34 551
Hanan Refai Egypt 15 660 1.6× 198 1.4× 86 0.7× 91 1.2× 164 2.4× 23 983
Riham M. El‐Moslemany Egypt 15 211 0.5× 146 1.0× 45 0.4× 38 0.5× 84 1.2× 27 616
Sadek Ahmed Egypt 15 324 0.8× 112 0.8× 60 0.5× 25 0.3× 71 1.0× 29 755
Hanan M. El-Laithy Egypt 16 685 1.6× 222 1.6× 104 0.9× 99 1.3× 120 1.7× 25 982
Yogeshwar Bachhav Switzerland 11 553 1.3× 62 0.4× 280 2.4× 98 1.3× 42 0.6× 14 771
Priscila Schilrreff Argentina 13 135 0.3× 190 1.3× 55 0.5× 39 0.5× 81 1.2× 17 583

Countries citing papers authored by Rofida Albash

Since Specialization
Citations

This map shows the geographic impact of Rofida Albash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rofida Albash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rofida Albash more than expected).

Fields of papers citing papers by Rofida Albash

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rofida Albash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rofida Albash. The network helps show where Rofida Albash may publish in the future.

Co-authorship network of co-authors of Rofida Albash

This figure shows the co-authorship network connecting the top 25 collaborators of Rofida Albash. A scholar is included among the top collaborators of Rofida Albash based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rofida Albash. Rofida Albash is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Albash, Rofida, et al.. (2025). Advanced Vaginal Nanodelivery of Losartan Potassium via PEGylated Zein Nanoparticles for Methicillin-Resistant Staphylococcus aureus. Pharmaceutics. 17(10). 1344–1344. 1 indexed citations
2.
Albash, Rofida, et al.. (2025). The Road to Precision Nanomedicine: An Insight on Drug Repurposing and Advances in Nanoformulations for Treatment of Cancer. AAPS PharmSciTech. 26(8). 237–237. 7 indexed citations
3.
4.
Albash, Rofida, et al.. (2025). Harnessing natural terpenes via PEGylated mucoadhesive vesicles for improved urinary bladder delivery: from in vitro evaluation to in vivo assessment. Frontiers in Pharmacology. 16. 1685423–1685423. 1 indexed citations
5.
El-Nabarawi, Mohamed A., Mariam Hassan, Maha M. Abdel‐Fattah, et al.. (2025). PEG-decorated emulsomal gel loaded levocetirizine dihydrochloride as repurposed cure for effective management of methicillin-resistant Staphylococcus aureus (MRSA) vaginal infection: D-optimal design optimization, ex-vivo, in-silico, and in-vivo studies. Journal of Drug Delivery Science and Technology. 115. 107680–107680. 1 indexed citations
6.
Albash, Rofida, et al.. (2025). Intranasal propranolol hydrochloride-loaded PLGA-lipid hybrid nanoparticles for brain targeting: Optimization and biodistribution study by radiobiological evaluation. European Journal of Pharmaceutical Sciences. 208. 107061–107061. 9 indexed citations
7.
Hassab, Mahmoud A. El, Mona H. Ibrahim, Sherif S. Abdel Mageed, et al.. (2025). Formulation of zein nanoparticles for augmenting the anti-inflammatory activity of dexketoprofen. Frontiers in Pharmacology. 16. 1560585–1560585. 6 indexed citations
8.
9.
Albash, Rofida, Hassan Mohamed El-Said Azzazy, Shaimaa Mosallam, et al.. (2025). Stearyl amine-modified elastic cerosomes for boosting the anti-cancer activity of albendazole. Frontiers in Pharmacology. 16. 1595177–1595177. 2 indexed citations
10.
Elhabal, Sammar Fathy, et al.. (2024). Transdermal fluocinolone acetonide loaded decorated hyalurosomes cellulose acetate/polycaprolactone nanofibers mitigated Freund’s adjuvant-induced rheumatoid arthritis in rats. Journal of Pharmaceutical Investigation. 55(1). 113–132. 22 indexed citations
11.
12.
Albash, Rofida, Eman F. Khaleel, Rehab Mustafa Badi, et al.. (2024). Sonophoresis mediated diffusion of caffeine loaded Transcutol® enriched cerosomes for topical management of cellulite. European Journal of Pharmaceutical Sciences. 201. 106875–106875. 12 indexed citations
13.
14.
15.
El-Nabarawi, Mohamed A., Mahmoud H. Teaima, Mariam Hassan, et al.. (2023). Integration of terpesomes loaded Levocetrizine dihydrochloride gel as a repurposed cure for Methicillin-Resistant Staphylococcus aureus (MRSA)-Induced skin infection; D-optimal optimization, ex-vivo, in-silico, and in-vivo studies. International Journal of Pharmaceutics. 633. 122621–122621. 22 indexed citations
16.
Mosallam, Shaimaa, et al.. (2022). Advanced Vesicular Systems for Antifungal Drug Delivery. AAPS PharmSciTech. 23(6). 206–206. 30 indexed citations
17.
Albash, Rofida, Menna M. Abdellatif, Mariam Hassan, & Noha M. Badawi. (2021). Tailoring Terpesomes and Leciplex for the Effective Ocular Conveyance of Moxifloxacin Hydrochloride (Comparative Assessment): In-vitro, Ex-vivo, and In-vivo Evaluation. International Journal of Nanomedicine. Volume 16. 5247–5263. 55 indexed citations
18.
19.
Albash, Rofida, Aly A. Abdelbary, Hanan Refai, & Mohamed A. El-Nabarawi. (2019). <p>Use of transethosomes for enhancing the transdermal delivery of olmesartan medoxomil: in vitro, ex vivo, and in vivo evaluation</p>. International Journal of Nanomedicine. Volume 14. 1953–1968. 120 indexed citations
20.
Albash, Rofida, Mohamed A. El-Nabarawi, Hanan Refai, & Aly A. Abdelbary. (2019). <p>Tailoring of PEGylated bilosomes for promoting the transdermal delivery of olmesartan medoxomil: in-vitro characterization, ex-vivo permeation and in-vivo assessment</p>. International Journal of Nanomedicine. Volume 14. 6555–6574. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Menna M. Abdellatif Breakdown of academic impact, for papers by Zaida Urbán‐Morlán Breakdown of academic impact, for papers by Sureewan Duangjit Breakdown of academic impact, for papers by Lalit Kumar Breakdown of academic impact, for papers by Hanan Refai Breakdown of academic impact, for papers by Riham M. El‐Moslemany Breakdown of academic impact, for papers by Sadek Ahmed Breakdown of academic impact, for papers by Hanan M. El-Laithy Breakdown of academic impact, for papers by Yogeshwar Bachhav Breakdown of academic impact, for papers by Priscila Schilrreff
Rankless by CCL
2026